Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tabor

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
JAMA|February 11, 1983
Newly licensed hepatitis B vaccine. Known safety and unknown risksR J Gerety, E Tabor
Lancet (London, England)|June 23, 1984
Five cases of Pseudomonas sepsis transmitted by blood transfusionsE Tabor, R J Gerety
The Journal of Infectious Diseases|November 1, 1980
Inactivation of an agent of human non-A, non-B hepatitis by formalinE Tabor, R J Gerety
Journal of Medical Virology|May 1, 1991
Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamineE Tabor, C M Kim
Vaccines|August 23, 2020
Cocktail Anti-Tick Vaccines: The Unforeseen Constraints and Approaches toward Enhanced EfficaciesCharles Ndawula, Ala E Tabor
International Journal of Oncology|July 31, 1999
Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell linesM Minemura, H Tanimura, E Tabor
Human Genetics|January 1, 1989
Ataxia-telangiectasia fibroblasts have less fibronectin mRNA than control cells but have the same levels of integrin and beta-actin mRNAY Becker, E Tabor, Y Asher
Clinical Immunology (Orlando, Fla.)|December 20, 2016
Estrogen receptor alpha promotes lupus in (NZB×NZW)F1 mice in a B cell intrinsic mannerDana E Tabor, Karen A Gould
Biochemical and Biophysical Research Communications|January 27, 1983
Repair of potentially lethal and sublethal damage induced by neocarzinostatin in normal and ataxia-telangiectasia skin fibroblastsY Shiloh, E Tabor, Y Becker
Virus Genes|January 1, 1991
Epstein-Barr virus BHRF1 gene but not the cellular protooncogene bcl-2 is expressed in ataxia-telangiectasia lymphoblastoid linesY Becker, E Tabor, Y Asher
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
JAMA|February 11, 1983
Newly licensed hepatitis B vaccine. Known safety and unknown risksR J Gerety, E Tabor
Lancet (London, England)|June 23, 1984
Five cases of Pseudomonas sepsis transmitted by blood transfusionsE Tabor, R J Gerety
The Journal of Infectious Diseases|November 1, 1980
Inactivation of an agent of human non-A, non-B hepatitis by formalinE Tabor, R J Gerety
Journal of Medical Virology|May 1, 1991
Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamineE Tabor, C M Kim
Vaccines|August 23, 2020
Cocktail Anti-Tick Vaccines: The Unforeseen Constraints and Approaches toward Enhanced EfficaciesCharles Ndawula, Ala E Tabor
International Journal of Oncology|July 31, 1999
Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell linesM Minemura, H Tanimura, E Tabor
Human Genetics|January 1, 1989
Ataxia-telangiectasia fibroblasts have less fibronectin mRNA than control cells but have the same levels of integrin and beta-actin mRNAY Becker, E Tabor, Y Asher
Clinical Immunology (Orlando, Fla.)|December 20, 2016
Estrogen receptor alpha promotes lupus in (NZB×NZW)F1 mice in a B cell intrinsic mannerDana E Tabor, Karen A Gould
Biochemical and Biophysical Research Communications|January 27, 1983
Repair of potentially lethal and sublethal damage induced by neocarzinostatin in normal and ataxia-telangiectasia skin fibroblastsY Shiloh, E Tabor, Y Becker
Virus Genes|January 1, 1991
Epstein-Barr virus BHRF1 gene but not the cellular protooncogene bcl-2 is expressed in ataxia-telangiectasia lymphoblastoid linesY Becker, E Tabor, Y Asher
Pageof 27